BMN 110 US Expanded Access Program



Status:Available
Conditions:Metabolic
Therapuetic Areas:Pharmacology / Toxicology
Healthy:No
Age Range:Any
Updated:5/3/2014
Contact:Amy Fowles
Email:bmn110eap@bmrn.cm

Use our guide to learn which trials are right for you!

A Multicenter, Open-label BMN 110 US Expanded Access Program (BMN 110 US EAP) to Provide BMN 110 to Patients Diagnosed With MPS IVA

The Expanded Access Program (EAP) is an open-label, multicenter program to:

1. Provide patients who have been diagnosed with Mucopolysaccharidosis IVA (MPS IVA)
access to BMN 110 until commercial product is available

2. Collect additional information on the safety and tolerability of BMN 110 administration
in patients with MPS IVA

Patients enrolled in the EAP will receive 2.0 mg/kg intravenous infusions of BMN 110 every
week during the program.


Inclusion Criteria:

- Diagnosed with MPS IVA as confirmed by either N-acetylgalactosamine-6-sulfatase
(GALNS) enzymatic test (GALNS activity in affected range, beta-galactosidase and a
second lysosomal sulfatase activity within normal range) or molecular diagnostic test
(two mutations in GALNS identified that have previously been associated with an
enzyme defect).

- Willing and able to provide written, signed informed consent, or in the case of
patients under the age of 18, provide written assent (as required by the IRB) and
written informed consent by a legally authorized representative after the nature of
the program has been explained, and prior to any program assessments or evaluations.

- Sexually active patients must be willing to use an acceptable method of contraception
while participating in the program.

- Females of childbearing potential must have a negative pregnancy test at Baseline and
be willing to have additional pregnancy tests during the program.

- Willing and able to comply with all program procedures.

Exclusion Criteria:

- Pregnant or breastfeeding at Baseline or planning to become pregnant (self or
partner) at any time during the program. Patients who become pregnant during the
program will be discontinued from the program.

- Currently enrolled in an ongoing clinical study of BMN 110.

- Discontinued from a BMN 110 clinical study secondary to a safety-related event.

- Use of any investigational product (other than BMN 110 in a clinical study) or
investigational medical device within 30 days prior to Baseline, or requirement for
any investigational agent prior to completion of all scheduled program assessments.

- Not a current US resident or expecting to have travel plans outside the US during the
planned period of participation in the Expanded Access Program (EAP) that may
interfere with dosing regimen, scheduled program visits and safety monitoring.

- Any condition that, in the view of the Investigator or sponsor, places the patient at
high risk of poor treatment compliance or of not completing the EAP.
We found this trial at
22
sites
?
mi
from
Oakland, CA
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Aurora, CO
Click here to add this to my saved trials
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Hollywood, FL
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
?
mi
from
Louisville, KY
Click here to add this to my saved trials
?
mi
from
Manhasset, NY
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Orange, CA
Click here to add this to my saved trials
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
?
mi
from
Portland, OR
Click here to add this to my saved trials
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
?
mi
from
Seattle, WA
Click here to add this to my saved trials
?
mi
from
Tacoma, WA
Click here to add this to my saved trials
?
mi
from
Washington,
Click here to add this to my saved trials